132 related articles for article (PubMed ID: 15556967)
21. Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.
Bohgaki T; Amasaki Y; Nishimura N; Bohgaki M; Yamashita Y; Nishio M; Sawada KI; Jodo S; Atsumi T; Koike T
Ann Rheum Dis; 2005 Aug; 64(8):1165-73. PubMed ID: 16014681
[TBL] [Abstract][Full Text] [Related]
22. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
24. Identification of SAP97 as an intracellular binding partner of TACE.
Peiretti F; Deprez-Beauclair P; Bonardo B; Aubert H; Juhan-Vague I; Nalbone G
J Cell Sci; 2003 May; 116(Pt 10):1949-57. PubMed ID: 12668732
[TBL] [Abstract][Full Text] [Related]
25. LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNFα-converting enzyme.
Ali M; Saroha A; Pewzner-Jung Y; Futerman AH
FEBS Lett; 2015 Aug; 589(17):2213-7. PubMed ID: 26183206
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.
Maskos K; Fernandez-Catalan C; Huber R; Bourenkov GP; Bartunik H; Ellestad GA; Reddy P; Wolfson MF; Rauch CT; Castner BJ; Davis R; Clarke HR; Petersen M; Fitzner JN; Cerretti DP; March CJ; Paxton RJ; Black RA; Bode W
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3408-12. PubMed ID: 9520379
[TBL] [Abstract][Full Text] [Related]
27. Modulation of monocytic lipopolysaccharide-induced tissue factor expression and tumor necrosis factor alpha release by estrogen and calcitriol.
Vlotides G; Gaertner R; Angstwurm MW
Hormones (Athens); 2007; 6(1):52-61. PubMed ID: 17324918
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol.
Zhang Z; Cork J; Ye P; Lei D; Schwarzenberger PO; Summer WR; Shellito JE; Nelson S; Kolls JK
J Leukoc Biol; 2000 Jun; 67(6):856-62. PubMed ID: 10857859
[TBL] [Abstract][Full Text] [Related]
29. Benzodiazepine inhibitors of the MMPs and TACE. Part 2.
Levin JI; Nelson FC; Delos Santos E; Du MT; MacEwan G; Chen JM; Ayral-Kaloustian S; Xu J; Jin G; Cummons T; Barone D
Bioorg Med Chem Lett; 2004 Aug; 14(16):4147-51. PubMed ID: 15261259
[TBL] [Abstract][Full Text] [Related]
30. The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding.
Killock DJ; Ivetić A
Biochem J; 2010 May; 428(2):293-304. PubMed ID: 20331435
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the surface expression of tumor necrosis factor alpha (TNFalpha) but not the p55 TNFalpha receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitors.
Glaser KB; Pease L; Li J; Morgan DW
Biochem Pharmacol; 1999 Feb; 57(3):291-302. PubMed ID: 9890556
[TBL] [Abstract][Full Text] [Related]
32. Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system.
Moro MA; Hurtado O; Cárdenas A; Romera C; Madrigal JL; Fernández-Tomé P; Leza JC; Lorenzo P; Lizasoain I
Neurosignals; 2003; 12(2):53-8. PubMed ID: 12876399
[TBL] [Abstract][Full Text] [Related]
33. Endotoxin recognition in fish results in inflammatory cytokine secretion not gene expression.
Roher N; Callol A; Planas JV; Goetz FW; MacKenzie SA
Innate Immun; 2011 Feb; 17(1):16-28. PubMed ID: 20083499
[TBL] [Abstract][Full Text] [Related]
34. Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
Rabinowitz MH; Andrews RC; Becherer JD; Bickett DM; Bubacz DG; Conway JG; Cowan DJ; Gaul M; Glennon K; Lambert MH; Leesnitzer MA; McDougald DL; Moss ML; Musso DL; Rizzolio MC
J Med Chem; 2001 Nov; 44(24):4252-67. PubMed ID: 11708926
[TBL] [Abstract][Full Text] [Related]
35. Shedding of membrane proteins by ADAM family proteases.
Moss ML; Lambert MH
Essays Biochem; 2002; 38():141-53. PubMed ID: 12463167
[TBL] [Abstract][Full Text] [Related]
36. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
Nita IM; Serapinas D; Janciauskiene SM
Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
[TBL] [Abstract][Full Text] [Related]
37. Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch.
Buckley CA; Rouhani FN; Kaler M; Adamik B; Hawari FI; Levine SJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1132-8. PubMed ID: 15749738
[TBL] [Abstract][Full Text] [Related]
38. Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells.
Sakamaki I; Fukushi M; Ohashi W; Tanaka Y; Itoh K; Tomihara K; Yamamoto Y; Iwasaki H
Sci Rep; 2021 Dec; 11(1):24154. PubMed ID: 34921186
[TBL] [Abstract][Full Text] [Related]
39. Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages.
Armstrong L; Godinho SI; Uppington KM; Whittington HA; Millar AB
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):219-25. PubMed ID: 16210695
[TBL] [Abstract][Full Text] [Related]
40. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate.
Hurtado O; Lizasoain I; Fernández-Tomé P; Alvarez-Barrientos A; Leza JC; Lorenzo P; Moro MA
J Cereb Blood Flow Metab; 2002 May; 22(5):576-85. PubMed ID: 11973430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
